中国的罕见病与立法 - Suppr

Suppr

超能文献

Rare diseases and legislation in China.

作者信息

Wang Jing-Bo, Guo Jeff J, Yang Li, Zhang Yan-De, Sun Zhao-Qi, Zhang Yan-Jun

机构信息

Department of Ophthalmology, People's Liberation Army 309 Hospital, Haidian, Beijing, China.

出版信息

Lancet. 2010 Feb 27;375(9716):708-9. doi: 10.1016/S0140-6736(10)60240-1.

DOI:10.1016/S0140-6736(10)60240-1

PMID:20189012

Abstract

摘要

相似文献

Rare diseases and legislation in China.

Lancet. 2010 Feb 27;375(9716):708-9. doi: 10.1016/S0140-6736(10)60240-1.

Rare disease patients in China anticipate the sunlight of legislation.

Drug Discov Ther. 2013 Jun;7(3):126-8.

Documenting rare disease data in China.

Science. 2015 Sep 4;349(6252):1064. doi: 10.1126/science.349.6252.1064-b.

Why reform health care?

J Med Assoc Ga. 2007;96(2):13-4.

Summertime advocacy focuses on health care reform.

Iowa Med. 2009 Jul-Aug;99(4):14.

[State of play of innovative experimentations in telemedicine].

Med Sci (Paris). 2018 May;34 Hors série n°1:33-35. doi: 10.1051/medsci/201834s118. Epub 2018 Jun 18.

[Current views on rare diseases research and orphan drugs development].

Sheng Wu Gong Cheng Xue Bao. 2011 May;27(5):724-9.

Managed care reform passes Senate: pressure moves to House.

Pa Med. 1998 Apr;101(4):1.

Queen's Speech promises libel reform and bill on adult social care.

BMJ. 2012 May 10;344:e3333. doi: 10.1136/bmj.e3333.

Step by step. Health-system reform finally progresses, incrementally.

Tex Med. 1996 Nov;92(11):24-8.

引用本文的文献

Patterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study.

JMIR Public Health Surveill. 2024 Aug 27;10:e57353. doi: 10.2196/57353.

Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges.

Orphanet J Rare Dis. 2022 Sep 10;17(1):352. doi: 10.1186/s13023-022-02507-2.

Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands With Genetic Skeletal Dysplasias.

Front Cell Dev Biol. 2021 Sep 7;9:715042. doi: 10.3389/fcell.2021.715042. eCollection 2021.

How Can Policymakers be Encouraged to Support People With Spinal Cord Injury-Scoping Review.

Global Spine J. 2022 May;12(4):732-741. doi: 10.1177/21925682211005406. Epub 2021 Apr 20.

What hinders congenital ectopia lentis patients' follow-up visits? A qualitative study.

BMJ Open. 2020 Mar 12;10(3):e030434. doi: 10.1136/bmjopen-2019-030434.

Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance.

Orphanet J Rare Dis. 2019 Aug 20;14(1):204. doi: 10.1186/s13023-019-1165-7.

Rare diseases in China: analysis of 2014-2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals.

Orphanet J Rare Dis. 2019 Jul 1;14(1):160. doi: 10.1186/s13023-019-1137-y.

Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China.

Chin Med J (Engl). 2018 Oct 5;131(19):2388-2389. doi: 10.4103/0366-6999.241814.

Defining rare diseases in China.

Intractable Rare Dis Res. 2017 May;6(2):148-149. doi: 10.5582/irdr.2017.01009.

Challenges in orphan drug development and regulatory policy in China.

Orphanet J Rare Dis. 2017 Jan 18;12(1):13. doi: 10.1186/s13023-017-0568-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验